RECORD // Company

Veracyte, Inc.

Formerly: CALDEROME INC

Built 2026-11-21T11:20:29Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
  • VERACYTE, INC. · legal entity in this company's GLEIF ownership tree (LEI 529900ESWZRHXOW27Z37)
SEC EDGAR (1)
Matched by name only, not merged (6)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Veracyte, Inc. · Ca business · same registered legal name as 'VERACYTE, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Veracyte, Inc. · Ctgov · same registered legal name as 'VERACYTE, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • VERACYTE · Epa echo · exact name match to 'VERACYTE, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • VERACYTE INC · Epa echo · same registered legal name as 'VERACYTE, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • VERACYTE, INC. · Epa echo · same registered legal name as 'VERACYTE, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • VERACYTE, INC. · USAspending · same registered legal name as 'VERACYTE, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare

4 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-05 · accession 0001384101-26-000055

ItemValuePeriodFormFiledAccessionReport
Revenue$151,754,0003 months ended 2026-09-3010-Q2026-11-050001384101-26-0000552026-11-21 11:20 UTCReport an error
Net income (loss)$31,503,0003 months ended 2026-09-3010-Q2026-11-050001384101-26-0000552026-11-21 11:20 UTCReport an error
Cash and cash equivalents$199,828,000at 2026-09-3010-Q2026-11-050001384101-26-0000552026-11-21 11:20 UTCReport an error
Contract liabilities, current$864,000at 2026-09-3010-Q2026-11-050001384101-26-0000552026-11-21 11:20 UTCReport an error

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001384101
Ticker
VCYT
EIN
205455398
CUSIP
92337F107
Record ID
sx:sec:0001384101

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

39 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-12SEC EDGAR company profile2026-11-21 11:20 UTCReport an error
SIC industry8071 Services-Medical Laboratories2026-11-12SEC EDGAR company profile2026-11-21 11:20 UTCReport an error
State of incorporationDE2026-11-12SEC EDGAR company profile2026-11-21 11:20 UTCReport an error
Fiscal year end (MMDD)12312026-11-12SEC EDGAR company profile2026-11-21 11:20 UTCReport an error
Business address6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 940802026-11-12SEC EDGAR company profile2026-11-21 11:20 UTCReport an error
ExchangesNasdaq2026-11-12SEC EDGAR company profile2026-11-21 11:20 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$517,145,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-21 11:20 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$66,353,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-21 11:20 UTCReport an error
Total assets (at 2025-12-31)$1,406,019,0002025-12-3110-K, XBRL Assets2026-11-21 11:20 UTCReport an error
Stockholders' equity (at 2025-12-31)$1,309,576,0002025-12-3110-K, XBRL StockholdersEquity2026-11-21 11:20 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$362,578,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-21 11:20 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$136,307,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 11:20 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$9,677,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-21 11:20 UTCReport an error
Operating lease liabilities (at 2025-12-31)$39,654,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-21 11:20 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-04)On November 4, 2026, Veracyte, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2026. The full text of the press release is furnished as Exhibit 99.1 to this report. The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific…2026-11-04SEC EDGAR 8-K 0001384101-26-000053 (text as filed, excerpt)2026-11-21 11:20 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-11-04)On November 4, 2026, the Company announced the commencement of a share repurchase program previously authorized by the Board of Directors of the Company, pursuant to which the Company may repurchase up to $100.0 million of its outstanding common stock during the one-year period beginning on the date of the public announcement of the program (the “Repurchase Program”). Repurchases under the Repurchase Program may be made from time to time in open-market transactions, including in accordance with Rule 10b-18 under the Exchange Act or pursuant to trading plans adopted in accordance with Rule 10b5-1 under the Exchange Act, privately negotiated transactions, accelerated share repurchase…2026-11-04SEC EDGAR 8-K 0001384101-26-000053 (text as filed, excerpt)2026-11-21 11:20 UTCReport an error
8-K Item 1.01, Entry into a Material Definitive Agreement (filed 2026-09-14)Merger Agreement On September 10, 2026, Veracyte, Inc., a Delaware corporation (“Veracyte”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Compass Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Veracyte (“Merger Sub”), Convergent Genomics Inc., a Delaware corporation (“Convergent”), and Shareholder Representative Services LLC, as the exclusive representative of the Securityholder Indemnifying Parties (as defined in the Merger Agreement) in connection with the transactions contemplated by the Merger Agreement. Pursuant to the terms of the Merger Agreement, on September 14, 2026, Merger Sub merged with and into Convergent, whereupon the…2026-09-14SEC EDGAR 8-K 0001384101-26-000049 (text as filed, excerpt)2026-11-21 11:20 UTCReport an error
8-K Item 2.01, Completion of Acquisition or Disposition of Assets (filed 2026-09-14)On September 14, 2026, Veracyte completed its acquisition of Convergent pursuant to the terms of the Merger Agreement. To the extent required by this Item 2.01, the information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.01.2026-09-14SEC EDGAR 8-K 0001384101-26-000049 (text as filed, excerpt)2026-11-21 11:20 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-09-14)On September 14, 2026, Veracyte issued a press release announcing the completion of its acquisition of Convergent. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 7.01. The information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such…2026-09-14SEC EDGAR 8-K 0001384101-26-000049 (text as filed, excerpt)2026-11-21 11:20 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-07-30)On July 30, 2026, Veracyte, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2026. The full text of the press release is furnished as Exhibit 99.1 to this report. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.2026-07-30SEC EDGAR 8-K 0001384101-26-000042 (text as filed, excerpt)2026-11-21 11:20 UTCReport an error
Employer name (as filed)Veracyte, Inc.2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:20 UTCReport an error
Certified LCAs42026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:20 UTCReport an error
Certified LCAs later withdrawn02026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:20 UTCReport an error
Total worker positions on certified LCAs42026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:20 UTCReport an error
Top job titles (title, LCA count)Sr. Technical Product Manager (1); Sr. Salesforce Developer (1); Scientist I (1); Senior LIMS Engineer (1)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:20 UTCReport an error
Wage offered, annualized (n, min, median, max)median $163,987 (range $140,213-$208,071, 4 filings)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:20 UTCReport an error
Worksite statesCA; MA2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:20 UTCReport an error
Plan (pension, plan no. 001)VERACYTE, INC. 401(K) PLAN: 912 participants, assets $78,422,5962025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:20 UTCReport an error
Plan (welfare, plan no. 502)VERACYTE HEALTH PLAN: 703 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:20 UTCReport an error
Largest institutional holder #1 (13F as filed): BlackRock, Inc.$792,058,4422026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:20 UTCReport an error
Largest institutional holder #2 (13F as filed): FMR LLC$452,382,2622026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:20 UTCReport an error
Largest institutional holder #3 (13F as filed): Artisan Partners Limited Partnership$325,270,4692026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:20 UTCReport an error
Largest institutional holder #4 (13F as filed): VANGUARD PORTFOLIO MANAGEMENT LLC$276,981,8972026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:20 UTCReport an error
Largest institutional holder #5 (13F as filed): STATE STREET CORP$275,953,0462026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:20 UTCReport an error
Largest institutional holder #6 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$211,071,0392026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:20 UTCReport an error
Largest institutional holder #7 (13F as filed): DIMENSIONAL FUND ADVISORS LP$166,011,1882026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:20 UTCReport an error
Largest institutional holder #8 (13F as filed): FIRST TRUST ADVISORS LP$147,289,0842026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:20 UTCReport an error
Largest institutional holder #9 (13F as filed): ARK Investment Management LLC$134,841,2222026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:20 UTCReport an error
Largest institutional holder #10 (13F as filed): WELLINGTON MANAGEMENT GROUP LLP$133,561,4172026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:20 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.